APA (7th ed.) Citation

Bakr, S., Dash, H. E., Youssef, A. A. A., & El‐Hamid, R. G. A. (2025). Differential Expression of BCL2 and IGFBP2 in Childhood Immune Thrombocytopenic Purpura Clinical Subtypes: Implications for Predicting Disease Progression and Apoptotic Regulation. Pediatric blood & cancer, 72(4), e31586-n/a. https://doi.org/10.1002/pbc.31586

Chicago Style (17th ed.) Citation

Bakr, Salwa, Hanaa El Dash, Asmaa Ahmed Ali Youssef, and Rehab Galal Abd El‐Hamid. "Differential Expression of BCL2 and IGFBP2 in Childhood Immune Thrombocytopenic Purpura Clinical Subtypes: Implications for Predicting Disease Progression and Apoptotic Regulation." Pediatric Blood & Cancer 72, no. 4 (2025): e31586-n/a. https://doi.org/10.1002/pbc.31586.

MLA (9th ed.) Citation

Bakr, Salwa, et al. "Differential Expression of BCL2 and IGFBP2 in Childhood Immune Thrombocytopenic Purpura Clinical Subtypes: Implications for Predicting Disease Progression and Apoptotic Regulation." Pediatric Blood & Cancer, vol. 72, no. 4, 2025, pp. e31586-n/a, https://doi.org/10.1002/pbc.31586.